跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“GZMB”
全部
16
临床试验
2
药物
3
机构
0
资讯
11
去年
FDA Approves IND for FP008, a Novel PD-1×IL-10M Fusion Protein for Resistant Solid Tumors
去年
Fapon Biopharma Enrolls First Patient in Phase I Trial of FP008, Novel Anti-PD-1 Fusion Protein for Solid Tumors
去年
Venetoclax Enhances CAR T-Cell Therapy Response in Chronic Lymphocytic Leukemia
去年
Oncolytic Virus and Toripalimab Combination Shows Promise in Acral Melanoma
去年
Machine Learning-Based Immune Risk Score Outperforms Traditional Methods in Predicting Colorectal Cancer Outcomes
去年
FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer
去年
Bacteria-Assisted Aptamer-Drug Conjugates Enhance Pancreatic Cancer Therapy
7个月前
CXCR4 Engineering Transforms CAR-T Cell Therapy: Enhanced Memory Formation and Durable Anti-Leukemic Immunity
11个月前
Researchers Develop Gene Signature to Predict Immunotherapy Response in Triple-Negative Breast Cancer
上个月
Post-translational modifications orchestrate CD8+ T cell exhaustion from signal initiation to epigenetic locking
第 1 页,共 2 页
上一页
下一页